propylthiouracil

Generic: propylthiouracil

Labeler: quagen pharmaceuticals llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name propylthiouracil
Generic Name propylthiouracil
Labeler quagen pharmaceuticals llc
Dosage Form TABLET
Routes
ORAL
Active Ingredients

propylthiouracil 50 mg/1

Manufacturer
QUAGEN PHARMACEUTICALS LLC

Identifiers & Regulatory

Product NDC 70752-171
Product ID 70752-171_4a15d422-7a6a-4b92-a4cf-3632250c9580
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA080154
Listing Expiration 2026-12-31
Marketing Start 2021-03-18

Pharmacologic Class

Established (EPC)
thyroid hormone synthesis inhibitor [epc]
Mechanism of Action
thyroid hormone synthesis inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 70752171
Hyphenated Format 70752-171

Supplemental Identifiers

RxCUI
198175
UPC
0370752171113
UNII
721M9407IY
NUI
N0000175918 N0000175917

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name propylthiouracil (source: ndc)
Generic Name propylthiouracil (source: ndc)
Application Number ANDA080154 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 50 mg/1
source: ndc
Packaging
  • 100 TABLET in 1 BOTTLE (70752-171-10)
  • 1000 TABLET in 1 BOTTLE (70752-171-11)
source: ndc

Packages (2)

Ingredients (1)

propylthiouracil (50 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "4a15d422-7a6a-4b92-a4cf-3632250c9580", "openfda": {"nui": ["N0000175918", "N0000175917"], "upc": ["0370752171113"], "unii": ["721M9407IY"], "rxcui": ["198175"], "spl_set_id": ["84eae11a-b572-4570-b288-ac2cdd374186"], "pharm_class_epc": ["Thyroid Hormone Synthesis Inhibitor [EPC]"], "pharm_class_moa": ["Thyroid Hormone Synthesis Inhibitors [MoA]"], "manufacturer_name": ["QUAGEN PHARMACEUTICALS LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (70752-171-10)", "package_ndc": "70752-171-10", "marketing_start_date": "20210318"}, {"sample": false, "description": "1000 TABLET in 1 BOTTLE (70752-171-11)", "package_ndc": "70752-171-11", "marketing_start_date": "20210318"}], "brand_name": "PROPYLTHIOURACIL", "product_id": "70752-171_4a15d422-7a6a-4b92-a4cf-3632250c9580", "dosage_form": "TABLET", "pharm_class": ["Thyroid Hormone Synthesis Inhibitor [EPC]", "Thyroid Hormone Synthesis Inhibitors [MoA]"], "product_ndc": "70752-171", "generic_name": "PROPYLTHIOURACIL", "labeler_name": "QUAGEN PHARMACEUTICALS LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "PROPYLTHIOURACIL", "active_ingredients": [{"name": "PROPYLTHIOURACIL", "strength": "50 mg/1"}], "application_number": "ANDA080154", "marketing_category": "ANDA", "marketing_start_date": "20210318", "listing_expiration_date": "20261231"}